Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K. S. Flatten
ATR Inhibition Broadly Sensitizes Ovarian Cancer Cells to Chemotherapy Independent of BRCA Status
Cancer Research
Cancer Research
Oncology
Evaluation of Lapatinib and Topotecan Combination Therapy: Tissue Culture, Murine Xenograft, and Phase I Clinical Trial Data
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Knockdown of Cathepsin�L Sensitizes Ovarian Cancer Cells to Chemotherapy
Oncology Letters
Cancer Research
Oncology
PARP Inhibition Sensitizes Colorectal Cancer-Initiating Cells to Chemotherapy
Stem Cells
Medicine
Molecular Medicine
Developmental Biology
Cell Biology
Reduced PAK1 Activity Sensitizes FA/BRCA-proficient Breast Cancer Cells to PARP Inhibition
Oncotarget
Oncology
Simultaneous Activation and Inhibition of Autophagy Sensitizes Cancer Cells to Chemotherapy
Oncotarget
Oncology
Genistein Sensitizes Cancer Cells to Chemotherapy: Table 1.
Cancer Research
Cancer Research
Oncology
Targeting HSF1 Sensitizes Cancer Cells to HSP90 Inhibition
Oncotarget
Oncology
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics
Targeting HER2 in Patient-Derived Xenograft Ovarian Cancer Models Sensitizes Tumors to Chemotherapy
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Phosphatidylinositol 3-Kinase Inhibition Broadly Sensitizes Glioblastoma Cells to Death Receptor- And Drug-Induced Apoptosis
Cancer Research
Cancer Research
Oncology